Easywell Biomedicals, Inc. (TPEX:1799)

Easywell Biomedicals Revenue

Easywell Biomedicals had revenue of 151.54M TWD in the quarter ending March 31, 2025, with 106.41% growth. This brings the company's revenue in the last twelve months to 618.56M, up 100.78% year-over-year. In the year 2024, Easywell Biomedicals had annual revenue of 540.44M with 98.96% growth.

• Revenue (ttm): 618.56M
• Revenue Growth: +100.78%
• P/S Ratio: 11.39
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 7.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	540.44M	268.81M	98.96%
Dec 31, 2023	271.63M	92.73M	51.83%
Dec 31, 2022	178.90M	-18.38M	-9.32%
Dec 31, 2021	197.28M	-70.38M	-26.29%
Dec 31, 2020	267.65M	-92.31M	-25.64%